Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Citations 1
Real-World Experience of Concomitant Isavuconazole and Vincristine Administration
Journal of the Pediatric Infectious Diseases Society | November 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
Three pediatric oncology patients received isavuconazole concurrently with vincristine across 15 days to approximately 23 months, spanning 32 vincristine doses. No severe adverse effect including neurotoxicity or paralytic ileus was attributed to the combination.